Vaccines, blood, antisera, toxins and cultures in   Tunisia

Exports In 2022, Tunisia exported $2.34M in Vaccines, blood, antisera, toxins and cultures, making it the 91st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 379th most exported product in Tunisia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Tunisia are: France ($1.39M), Mauritania ($903k), Belgium ($16.5k), Germany ($12.9k), and Libya ($6.81k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Tunisia between 2021 and 2022 were France ($524k), Mauritania ($91.6k), and Belgium ($16.3k).

Imports In 2022, Tunisia imported $139M in Vaccines, blood, antisera, toxins and cultures, becoming the 91st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 41st most imported product in Tunisia. Tunisia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($33.5M), Switzerland ($22.6M), Belgium ($15.4M), France ($13.8M), and Bahrain ($10.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Tunisia between 2021 and 2022 were Germany ($11.4M), Bahrain ($10.8M), and India ($4.42M).